Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
I-Mab Receives Top Rankings in Five Categories by Institutional Investor 2022-06-23 20:00
Short Videos of Traditional Chinese Medicine Culture Go Viral on YouTube 2022-06-23 11:14
Mojia Biotech Completes Series B Financing to Advance Manufacturing of Bio-based Materials 2022-06-23 09:00
China Pharma Announces Receipt of Noncompliance Notice from NYSE American 2022-06-23 05:00
Scientists take the first step to master an all-powerful cell type in the beginning of life 2022-06-21 23:10
Prof. Cho, head of the lung cancer center at Yonsei Cancer Hospital, "J INTS BIO's new oral administration 4th generation EGFR TKI 'JIN-A02' expected to be a game changer" 2022-06-21 17:00
Nippon Express Launches New Transport Service Using Environment-friendly Isothermal Packaging 2022-06-21 14:00
Therorna completes Series A financing to accelerate pipeline development and clinical transformation of circRNA-based platform 2022-06-21 08:00
Acepodia Announces FDA Clearance of IND Application for ACE1831, an Anti-CD20 Armed Allogeneic gamma delta T-cell Therapy Candidate to Treat Patients with non-Hodgkin's Lymphoma 2022-06-20 20:00
2022 Tang Prize in Biopharmaceutical Science Honors Three Scientists for Developing COVID-19 mRNA Vaccines 2022-06-19 10:30
2022 Tang Prize in Biopharmaceutical Science Honors Three Scientists for Developing COVID-19 mRNA Vaccines 2022-06-19 10:30
Memorial MRI & Diagnostic Installs United Imaging's Pioneering 75 cm, Ultra-Wide-Bore uMR OMEGA™ 2022-06-17 21:00
US FDA AWARDS ORPHAN DRUG DESIGNATION (ODD) TO PAXALISIB FOR AT/RT, A RARE FORM OF CHILDHOOD BRAIN CANCER 2022-06-17 20:00
Lunit Files Registration Statement for Initial Public Offering 2022-06-16 21:00
Bon Natural Life Limited Introduces New Powder Drink For Anti-H. Pylori and Digestive Health 2022-06-16 20:30
111, Inc. Announces First Quarter 2022 Unaudited Financial Results 2022-06-16 15:58
WuXi ATU and Wugen Announce Manufacturing Partnership to Expedite the Delivery of Novel Cell Cancer Immunotherapies 2022-06-16 08:00
I-Mab Partner MorphoSys Announces New License Agreements for Felzartamab and TJ210 2022-06-15 22:37
Burning Rock Presents Latest Clinical Data from THUNDER Study at 2022 ASCO Annual Meeting 2022-06-15 20:01
Waterdrop Inc. Announces First Quarter 2022 Unaudited Financial Results 2022-06-15 14:50
1 141 142 143 144 145 801